RELAPSED LARGE B-CELL LYMPHOMA
Clinical trials for RELAPSED LARGE B-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED LARGE B-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for RELAPSED LARGE B-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising drug offers hope for lymphoma patients who Can't get transplants
Disease control Recruiting nowThis study tests a drug called epcoritamab in people with a type of blood cancer called large B-cell lymphoma that has come back or not responded to treatment. Participants cannot have a stem cell transplant. The goal is to see if the drug can stop the cancer from growing for at …
Matched conditions: RELAPSED LARGE B-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Engineered immune cells take on Hard-to-Treat lymphoma in new trial
Disease control Recruiting nowThis study tests a new treatment called TC011, which uses a patient's own immune cells modified to find and attack cancer cells. It is for adults with large B-cell lymphoma that has come back or not responded to at least two prior treatments. The trial aims to find the safest dos…
Matched conditions: RELAPSED LARGE B-CELL LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: TICAROS Co., Ltd. • Aim: Disease control
Last updated May 20, 2026 11:55 UTC